by Madaline Spencer | Jul 17, 2026
Elif Oral, MD, Professor at the University of Michigan, discusses advances in lipodystrophy research presented at ENDO 2026. Lipodystrophies are rare metabolic disorders characterized by the loss of adipose tissue. This leads to complications such as...
by Madaline Spencer | Jul 16, 2026
Evelien Gevers, PhD, MD, Consultant Pediatrician and Reader in Endocrinology and Diabetes at Barts Health NHS Trust, discusses effects of diazoxide choline extended release (DCCR) on hyperphagia in patients with Prader-Willi syndrome (PWS). PWS is a rare...
by Madaline Spencer | Jul 15, 2026
Katie Gillick, Patient Advocate at Orsini Specialty Pharmacy, discusses the importance of patient and physician communication in the care of hypoparathyroidism. Hypoparathyroidism is a rare endocrine disorder in which the parathyroid glands do not...
by Madaline Spencer | Jul 14, 2026
The US Food and Drug Administration (FDA) has approved Orca-T (Tregzi), the first regulatory T cell-based immunotherapy for improving chronic graft-versus-host disease (GVHD)-free survival in adult patients with blood cancers undergoing allogeneic hematopoietic stem...
by Madaline Spencer | Jul 14, 2026
Maria Vogiatzi, MD, Division of Endocrinology at the Children’s Hospital of Philadelphia, discusses the effect of Crenessity (crinecerfont) on bone age advancement in patients with congenital adrenal hyperplasia (CAH). CAH refers to a group of...
